Healthcare Global Enterprises Ltd IPO (Healthcare Global IPO) Detail

Mar 16, 2016 - Mar 18, 2016

Healthcare Global Enterprises Ltd (HCG) is Bangalore India based provider of speciality healthcare in India focused on cancer and fertility.

HCG operates the largest cancer care network in India in terms of the total number of private cancer treatment centres licensed. HCG also operates fertility centres under the 'Milann' brand.

As of December 31, 2015, HCG network consisted of 14 comprehensive cancer centres, including centre of excellence in Bengaluru, three freestanding diagnostic centres and one day care chemotherapy centre across India.

HCG acquired 50.10% equity in BACC Healthcare in 2013 which operates fertility centres under the Milann brand, through itself and its wholly-owned subsidiary, DKR Healthcare. HCG now operate four Milann fertility centres in Bengaluru. BACC Healthcare is led by a team of qualified and experienced fertility specialists. Its founder, Dr. Kamini Rao has a successful track record of over 25 years of providing fertility treatments. Milann fertility centres provide comprehensive reproductive medicine services, including assisted reproduction, gynaecological endoscopy and fertility preservation; and follow a multidisciplinary and technology-focused approach to diagnosis and treatment.

Under Triesta brand, HCG provide clinical reference laboratory services in India with a specialisation in oncology, including molecular diagnostic services and genomic testing. Triesta central reference laboratory is located in centre of excellence in Bengaluru.

Strengths of the Company:
1. Largest provider of cancer care in India with a proven track record
2. High quality cancer care provided at a competitive price
3. Entry into high potential fertility business
4. Strong management team with successful track record
5. Highly skilled specialist physicians
6. 'hub and spoke' business model and partnership arrangements

Company Financials


For the year/period ended (in Rs. Million)
  31-Mar-15 31-Mar-14 31-Mar-13 31-Mar-12 31-Mar-11
Total Liabilities 6,895.42 6,138.21 6,436.40 4,362.63 3,203.63
Total Assets 6,895.42 6,138.21 6,436.40 4,362.63 3,203.63
Total Revenue 4,244.41 3,525.94 2,939.52 2,051.67 1,601.43
Profit After Tax (PAT) (23.66) (394.98) (71.58) (40.02) 34.40

Objects of the Issue

The Offer comprises of Fresh Issue and the Offer for Sale.

Offer for Sale
Company will not receive any proceeds from the Offer for Sale.

Fresh Issue
Company proposes to utilise the Net Proceeds towards funding the following objects:
1. Purchase of medical equipment;
2. Investment in IT software, services and hardware;
3. Pre-payment of debt; and
4. General corporate purposes.

Healthcare Global IPO Details

Healthcare Global IPO Date Mar 16, 2016 to Mar 18, 2016
Healthcare Global IPO Face Value ₹10 per share
Healthcare Global IPO Price ₹205 to ₹218 per share
Healthcare Global IPO Lot Size 65 Shares
Issue Size29,800,000 shares of ₹10
(aggregating up to ₹649.64 Cr)
Issue Type Book Built Issue IPO
Listing At BSE, NSE
Company Promoters

Dr. BS Ajai Kumar, Dr. KS Gopinath, Dr. Ganesh Nayak, Dr. M Gopichand and Dr. BS Ramesh are the Promoters of the Company.

Healthcare Global IPO Lot Size

The Healthcare Global IPO lot size is 65 shares. A retail-individual investor can apply for up to 14 lots (910 shares or ₹198,380).

Application Lots Shares Amount
Retail (Min) 1 65 ₹14,170
Retail (Max) 14 910 ₹198,380

Healthcare Global IPO Review

Although the company’s performance has been in negative zone, unique model of Cancer and Fertility treatment under HCG and Milann brands are expected to generate positive earnings in next two to three years. Long term investors may consider investment for adding value on their investment.

Read detail review...

Healthcare Global IPO Subscription Status (Bidding Detail)

The Healthcare Global IPO is subscribed 1.56 times on Mar 18, 2016 1:00:00 PM. The public issue subscribed 0.83 times in the retail category, 2.36 times in the QIB category, and 0.43 times in the NII category. Check Day by Day Subscription Details (Live Status)

CategorySubscription (times)

Healthcare Global IPO Prospectus

Healthcare Global IPO Rating

Rating:Rated 3.3 stars
Vote Here ...

Healthcare Global IPO Listing Date

Listing Date Wednesday, March 30, 2016
BSE Script Code 539787
NSE Symbol HCG
Listing In B Group of Securities
ISIN INE075I01017
IPO Price ₹218 per share
Face Value ₹10 per share

Listing Day Trading Information

IPO Price
Last Trade

Company Contact Information

Healthcare Global Enterprises Ltd
HCG Tower, No. 8, P Kalinga Rao Road,
Sampangi Rama Nagar,
Bengaluru 560 027
Phone: +91 80 4660 7700

Healthcare Global IPO Registrar

KFin Technologies Limited

Phone: 04067162222, 04079611000

Healthcare Global IPO FAQs

Healthcare Global IPO is a main-board IPO of 29,800,000 equity shares of the face value of ₹10 aggregating up to ₹649.64 Crores. The issue is priced at ₹205 to ₹218 per share. The minimum order quantity is 65 Shares.

The IPO opens on Mar 16, 2016, and closes on Mar 18, 2016.

KFin Technologies Limited is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

The Healthcare Global IPO opens on Mar 16, 2016 and closes on Mar 18, 2016.

Healthcare Global IPO lot size is 65 Shares and the minimum order quantity is .

You can apply in Healthcare Global IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank and SBI Bank.

The finalization of Basis of Allotment for Healthcare Global IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Healthcare Global IPO allotment status.

The Healthcare Global IPO listing date is on Wednesday, March 30, 2016.
Open an Instant Account with Zerodha

Healthcare Global IPO Message Board

Ranked Members of Forum  Ranked Members | Most Liked Members



311. Carn Mohan |   Link |Apr 1, 2016 12:13:29 PM
IPO Mentor IPO Mentor (900+ Posts, 400+ Likes)
Never invest in IPO/FPO is a golden rule. your hard earned money.
310. Carn Mohan |   Link |Apr 1, 2016 9:27:36 AM
IPO Mentor IPO Mentor (900+ Posts, 400+ Likes)
If any IPO down 20% there are 100% full allotment.
if any IPO up 15% there are allotment ratio 10:1 or 20:1
IPO investors always losers.
310.1. Virat Karani |   Link |Apr 1, 2016 9:44:18 AM
HCG has not 35% retail quota. It is slight above 15% so only retailer is losers is myth

Small investor contribute only 15% it might possible investor number are 80% but their contribution is only around 15%
309. rahoolgupta |   Link |Mar 31, 2016 2:38:02 PM
Now it is at 179/-.
Rising up slowly....
308. PearlRohit |   Link |Mar 31, 2016 11:39:40 AM
Top Contributor Top Contributor (200+ Posts, 100+ Likes)
307. Shibu |   Link |Mar 31, 2016 9:23:13 AM
HCG - Such a disappointment.........Hope it comes back to 218
306. Rajeev Kumar Singh |   Link |Mar 31, 2016 3:09:38 AM
Buy Bank of Baroda asap. Reasons- it was the most effected by vijay mallaya scandal. Secondly it had done higher provisioning for NPAs on loans given to VM. Now with possibility of 4k crore+ 2k crore out of 9k crore repayment by VM the balance sheets of banks would become better n if held for 2-3 yrs can give multifold returns. Do not miss the opportunity. BOB is avl at beaten down prices.
306.1. Rajeev Kumar Singh |   Link |Mar 31, 2016 3:11:37 AM
Expect price of Vedanta n Hind Zinc to jump anywhere between 5-10% or more on 31 mar. For those in intra day its a good buy.
305. Carn Mohan |   Link |Mar 30, 2016 9:14:03 PM
IPO Mentor IPO Mentor (900+ Posts, 400+ Likes)
Bhai logo ak kahawat suni hogi
Andher nagri caupat raja taka ser bahji taka ser kaja

Ha Ha Ha
305.1. PearlRohit |   Link |Mar 31, 2016 11:42:14 AM
Top Contributor Top Contributor (200+ Posts, 100+ Likes)
304. Viraj |   Link |Mar 30, 2016 9:05:06 PM
IPO Mentor IPO Mentor (800+ Posts, 1100+ Likes)
High veluasion,anothr qh
303. DCC |   Link |Mar 30, 2016 8:24:16 PM
Hcg proved it''s slogan

Adding life to years


These life years for retailers should pass in waiting to get their hard earned money back..

I m loading faith on IPO.

Sebi not reviewed offer price.

Sebi is mother of retail investors , and if mother don''t care that child''s future is like orphan.

Good bye to IPO.
303.1. Septa |   Link |Mar 30, 2016 9:01:24 PM
IPO Guru IPO Guru (4000+ Posts, 4600+ Likes)
IMO the strategy should be apply quality not quantity that be selective in applying for IPOs i have missed few good listing being selective but at least i have not many flops intact in 5 years i only had three bad ones still below issue price but this selective process i also missed half a dozen good ones too
302. Gravitas |   Link |Mar 30, 2016 8:02:30 PM
Top Contributor Top Contributor (200+ Posts)
HCG corrected 22% on listing day itself & I thought I''d seen the worst in QH..
302.2. Septa |   Link |Mar 30, 2016 8:39:59 PM
IPO Guru IPO Guru (4000+ Posts, 4600+ Likes)
today on CNBC TV18 the CEO sounded very less caring being a Dr himself when asked abt the price was high... Infant the reporter was good with a counter question how can he be so casual since now he is head of a listed company.....I think many applied seeing 3 successful health care IPO one big difference was QIB portion anyway..... this will reduce flippers for sure more IPOs go wrong less the demand better pricing end result good for RI....

I am more worried about the dog with rabies BWR
302.3. Gravitas |   Link |Mar 31, 2016 2:08:56 AM
Top Contributor Top Contributor (200+ Posts)
Dog with rabies...:) this comment always tickles a funny bone.
301. Akshay More |   Link |Mar 30, 2016 6:49:07 PM
I have two lots what to do. Any chance of it going to 200 levels
300. Googly |   Link |Mar 30, 2016 6:07:24 PM
here always confusion

who is real and who is fake?
300.1. starsipo |   Link |Mar 30, 2016 6:11:08 PM
Fake people never last to 10 years....
299. starsipo |   Link |Mar 30, 2016 4:39:40 PM
Ms word , you are 100% right.....biased people pasting my advice but never post my others advised on H... I am sure they are unnerved after my posting on equitas....or about Lehman brothers story......
299.2. Rajeev Kumar Singh |   Link |Mar 30, 2016 6:29:13 PM
He hardly had any advice on HCG. Except the ones already pasted. For any doubt click his name I''d n read his messages on HCG. does he think that people will read his emotional writeup above n believe him? Everyone to be clear do read his write ups on HCG by clicking his name I''d. Just to clear things up.
299.3. starsipo |   Link |Mar 30, 2016 6:34:26 PM
Other advises means on NH.....lolz
298. Carn Mohan |   Link |Mar 30, 2016 4:15:05 PM
IPO Mentor IPO Mentor (900+ Posts, 400+ Likes)
if any IPO down 25% on listing 100% full allotment to retail investors.
if any IPO up 15% than allotment ratio 10:1 or 20:1 to retail investors.
there fore retailers always losers in IPO.
take care retailers.
298.1. Virat Karani |   Link |Apr 1, 2016 9:42:32 AM
HCG has not 35% retail quota. It is slight above 15%.

Small investor contribute only 15% it might possible investor number are 80% but their contribution is only around 15%.
297. Carn Mohan |   Link |Mar 30, 2016 2:51:46 PM
IPO Mentor IPO Mentor (900+ Posts, 400+ Likes)
Be careful all IPO /fpos and your hard earn money.
296. starsipo |   Link |Mar 30, 2016 1:55:08 PM
This is message no I6 of well-known expert....MO fundamental one should apply... I am going to apply this issue for sure....
296.1. Septa |   Link |Mar 30, 2016 2:06:41 PM
IPO Guru IPO Guru (4000+ Posts, 4600+ Likes)
Pls read the comments after that too as why I think my spoke and hub model will not work and valuation cannot be same as other hospitals.
295. Bullishbear |   Link |Mar 30, 2016 1:49:50 PM
They say the hindsight is 20/20
295.1. Septa |   Link |Mar 30, 2016 3:39:48 PM
IPO Guru IPO Guru (4000+ Posts, 4600+ Likes)
for me the valuation was not right given it hub and spoke model that is reason i said avoid anyway hope pricing of IPO in future r priced reasonable
295.2. Bullishbear |   Link |Mar 30, 2016 4:16:46 PM
Right Septa, I remember reading your views on this and benefitting from the same. Hope the weak listing of HCG puts some sense in small investors and lead managers.
294. Shrewd Trader |   Link |Mar 30, 2016 1:16:53 PM
This was my reason for avoiding this issue, I had posted it earlier too :

Cons: (1)corporate governance issues like frauds by employees, criminal proceedings against promoters
(2) specialist doctors are not employees but work on contract basis
(3) HCG is highly indebted company
(4)loss making co. for past several years
(5) despite losses valuations almost equal to Apollo Hospital
(6) Total liability to Networth is as high as 1.9
(7) OCF is just 12 % of Sales
(8) Interest cover is around 1 only

293. IPOInvestorOnly |   Link |Mar 30, 2016 1:13:36 PM
What is the fair value of this stock if one wants to buy?
293.1. Viraj |   Link |Mar 30, 2016 2:48:02 PM
IPO Mentor IPO Mentor (800+ Posts, 1100+ Likes)
156 is very attrective leval
292. ABHISHEK AHMEDABAD |   Link |Mar 30, 2016 1:00:02 PM
Ahmedabad grey market news zindabad perfect news